Where should investors be putting their money—and what should they avoid? Doug Kreps, principal and managing director at Fort Pitt Capital Group, and Brett D’arcy, CIO of CBIZ Wealth Management, shared their investing “tricks and treats” in honor of Halloween.
New York Attorney General Andrew Cuomo and 14 other states are filing a lawsuit against Amgen, alleging that the biotech company was offering kickbacks to medical providers to increase the sale of its anemia drug Aranesp.
Cramer makes the call on viewers' favorite stocks.
At the end of September, we looked at analysts' price targets for the S&P 500 to see which stocks had the greatest expected gains in the months ahead. So far, 3 out of the October 1 top 5 and 6 out of the top 10 are trading to the upside. Here is the current list of 15 stocks expected to pop (and another 15 expected to drop).
Stocks advanced Thursday as investors seemed to focus more on some big-name earnings beats and a rise in leading indicators instead of a disappointing jobless report. Travelers and MMM led the Dow.
Stocks advanced Thursday as investors seemed to focus more on some big-name earnings beats and a rise in leading indicators instead of a disappointing jobless report.
Stocks slipped Thursday as investors weighed a disappointing jobless-claims report and some encouraging earnings reports.
Earnings continue to come in largely above expectations, but other factors are waylaying the stock market's recent advances - ranging from Walmart's price cuts to analyst Richard Bove's downgrade of Wells Fargo to rising oil prices.
With Amgen dropping after hours and Merck, Celgene and others reporting earnings on Thursday, how should you game health care?
Amgen reported quarterly results that outpaced what Wall Street was expecting, and the company boosted its outlook for its full-year profit. But the company's shares declined in extended trading.
Stocks finished lower after well-known banking analyst Dick Bove downgraded his rating on Wells Fargo.
Stocks advanced Wednesday as investors were encouraged by a few earnings reports, including Morgan Stanley, Yahoo and SanDisk. The VIX, widely considered the best gauge of fear in the market, dropped to just above 20.
Stocks opened lower Wednesday as a raft of companies beating earning estimates but failed to impress investors.
Earnings season continues in earnest Wednesday, as we roll on with a week that will ultimately see 25 percent of the S&P 500 report their quarterly numbers.
Biotech investors will be closely watching results from Amgen on Wednesday. How should you game this stock into earnings?
Stocks rallied Monday, after a wobbly start, as investors were optimistic about the slew of earnings ahead.
Stocks rallied Monday, after a wobbly start, as techs dragged but investors were optimistic about the slew of earnings ahead.
In case you weren't aware, tomorrow is "World Osteoporosis Day" or WOD, for short, as the International Osteoporosis Foundation hilariously refers to it, but biotech Amgen won't be celebrating the occasion.
Stocks moved higher Monday, after a wobbly start, as techs dragged but investors were optimistic about the slew of earnings ahead.
Stocks continued to struggle on Friday. Could this be the beginning of a real market correction? Mike Rubino, president of Rubino Financial, and Paul Schatz, president of Heritage Capital, discussed how investors should position their portfolios for the end of the third quarter.